Abstract
This short report presents the results of a comparison of complete remission rates and reasons for failure, between two series of patients aged 60 years or over with acute myeloid leukaemia (AML), and discusses their interpretation.
MeSH terms
-
Acute Disease
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cytarabine / administration & dosage
-
Daunorubicin / administration & dosage
-
Disease-Free Survival
-
Humans
-
Leukemia, Myeloid / drug therapy*
-
Remission Induction
-
Thioguanine / administration & dosage
Substances
-
Cytarabine
-
Thioguanine
-
Daunorubicin